Given the need for accelerated bioprocessing operations, low-volume bioreactors have emerged as a relatively economic solution for parallelized cell cultivations ..
Owing to their vast potential in controlling disease-associated gene expression, RNAi therapeutics have emerged as a key segment of the market; several ..
Owing to their vast potential in controlling disease-associated gene expression, RNAi therapeutics have emerged as a key segment of the market; several ..
In order to avail benefits, such as technical competence, reduced cost, and fast delivery of high-quality DNA and gene customized clones, several players ..
Steadily growing demand for biologic fill / finish services has generated a range of new opportunities for contract service providers The current landscape ..
Steadily growing demand for biologic fill / finish services has generated a range of new opportunities for contract service providers The current landscape ..
Steadily growing demand for biologic fill / finish services has generated a range of new opportunities for contract service providers The current landscape ..
Steadily growing demand for biologic fill / finish services has generated a range of new opportunities for contract service providers The current landscape ..
Steadily growing demand for biologic fill / finish services has generated a range of new opportunities for contract service providers The current landscape ..
The current landscape of biologics fill / finish contract service providers features the presence of several established and emerging players, with a diverse ..
The current landscape of biologics fill / finish contract service providers features the presence of several established and emerging players, with a diverse ..
With the increasing concept of precision medicine, several scientists have demonstrated interest in the therapeutic manipulation of human microbiome (commonly ..
Over the years, advances in recombinant DNA technology and ex vivo synthesis of biomolecules have led to the development and (in some cases) approval of several ..
An exponential increase in the annual cost burden due to needlestick injuries, has fueled a corresponding rise in demand for safe and highly advanced safety ..
Aptamers have gained a lot of momentum in the past decade. It is worth highlighting that in 2005, Macugen became the first and the only USFDA approved ..
In recent years, the potential of cell invasion and migration assays with respect to discovery, diagnosis and screening of diseases has been widely recognized, ..
In order to avail benefits, such as technical competence in sequencing large-sized genes, reduced cost, and fast delivery of high-quality data, researchers ..
Given their low immunogenicity, diversified targets and ability to offer higher biosafety, the adeno-associated viral vectors are actively being evaluated ..
Innovation is considered to be one of the key drivers of the pharmaceutical industry. Over the past few decades, various technological advances and a few fortuitous ..
Given the growing number of patients suffering from cardiovascular disorders and the high associated financial burden, cardiovascular drug eluting stents ..
An exponential increase in the annual cost burden due to needlestick injuries, has fueled a corresponding rise in demand for safe and highly advanced safety ..
Amongst the total players involved in the development of RNA extraction and purification kits and reagents, majority of the players engaged in the development ..
Aptamers have gained a lot of momentum in the past decade. It is worth highlighting that in 2005, Macugen became the first and the only USFDA approved ..
Given the various challenges associated with co-development of companion diagnostics and drug / therapy, drug developers prefer to rely on third-party ..